Filing Details
- Accession Number:
- 0001250853-17-000060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-06 17:50:44
- Reporting Period:
- 2017-07-03
- Filing Date:
- 2017-07-06
- Accepted Time:
- 2017-07-06 17:50:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561743 | Kindred Biosciences Inc. | KIN | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1337252 | Richard Chin | C/O Kindred Biosciences, Inc. 1555 Bayshore Hwy., Suite 200 Burlingame CA 94010 | President And Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-07-03 | 13,000 | $8.26 | 2,297,546 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.15 to $8.65, inclusive. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2017.